These results demonstrate that the degree of injury in TNFR2KO was reduced suggesting this receptor's involvement in the inflammatory changes leading to the development of glomerular sclerosis during chronic AngII‐treatment as observed in our previous study (Singh et al., 2013). The gene discussed is AGT; the disease is Glomerular sclerosis.